| Drug NDC: | 43742-1506 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. | |
| Proprietary Name: | Rage |
| Also known as the trade name. It is the name of the product chosen by the labeler. | |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. | |
| Non Proprietary Name: | Apis Mellifica, Cantharis, Chamomilla, Adrenalinum, Cerebrum Suis, Hypophysis Suis, Aconitum Napellus, Agaricus Muscarius, Atropinum, Causticum, Cicuta Virosa, Cuprum Metallicum, Hyoscyamus Niger, Lac Caninum, Moschus, Stramonium, Tarentula Hispana, Veratrum Album, Homarus, Camphora |
| Also known as the generic name, this is usually the active ingredient(s) of the product. | |
| Labeler Name: | Deseret Biologicals, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. | |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. | |
| Substance Name: | ACONITUM NAPELLUS - 12 [hp_X]/mL AMANITA MUSCARIA FRUITING BODY - 12 [hp_X]/mL APIS MELLIFERA - 6 [hp_X]/mL ATROPINE - 12 [hp_X]/mL CAMPHOR (NATURAL) - 30 [hp_X]/mL CANIS LUPUS FAMILIARIS MILK - 12 [hp_X]/mL CAUSTICUM - 12 [hp_X]/mL CICUTA VIROSA ROOT - 12 [hp_X]/mL COPPER - 12 [hp_X]/mL DATURA STRAMONIUM - 12 [hp_X]/mL Load more... EPINEPHRINE - 8 [hp_X]/mL HOMARUS AMERICANUS DIGESTIVE FLUID - 17 [hp_X]/mL HYOSCYAMUS NIGER - 12 [hp_X]/mL LYCOSA TARANTULA - 12 [hp_X]/mL LYTTA VESICATORIA - 6 [hp_X]/mL MATRICARIA CHAMOMILLA - 6 [hp_X]/mL MOSCHUS MOSCHIFERUS MUSK SAC RESIN - 12 [hp_X]/mL SUS SCROFA CEREBRUM - 8 [hp_X]/mL SUS SCROFA PITUITARY GLAND - 8 [hp_X]/mL VERATRUM ALBUM ROOT - 12 [hp_X]/mL |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. | |
| Route Details: | ORAL |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Start Date: | 25 Jul, 2019 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. | |
| Marketing End Date: | 23 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. | |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. | |
| Manufacturer Name: | Deseret Biologicals, Inc. |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. | |
| Original Packager: | Yes |
| Whether or not the drug has been repackaged for distribution. | |
| NUI: | N0000185021 N0000175629 N0000184306 N0000185001 M0000728 M0002274 N0000175574 N0000175370 N0000175700 N0000000125 M0005152 N0000175831 N0000008595 N0000008924 N0000175830 N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647 |
| Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT). | |
| UNII: | U0NQ8555JD DIF093I037 7S82P3R43Z 7C0697DR9I N20HL7Q941 G39P120JQT DD5FO1WKFU YEA9P21S8N 789U1901C5 G6W4F0V8Z3 Load more... YKH834O4BH 4T1TW8LE2W 4WRK2153H3 86M454L2TT 3Q034RO3BT G0R4UBI2ZZ 8KFK4W7KP7 4GB5DQR532 L0PFEMQ1DT QNS6W5US1Z |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. | |
| Pharmacologic Class MOA: | Cholinergic Antagonists [MoA] Cholinergic Muscarinic Antagonists [MoA] Adrenergic alpha-Agonists [MoA] Adrenergic beta-Agonists [MoA] |
| Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`. | |
| Pharmacologic Class EPC: | Standardized Insect Venom Allergenic Extract [EPC] Anticholinergic [EPC] Cholinergic Muscarinic Antagonist [EPC] Copper-containing Intrauterine Device [EPC] alpha-Adrenergic Agonist [EPC] beta-Adrenergic Agonist [EPC] Catecholamine [EPC] |
| Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`. | |
| Pharmacologic Class PE: | Increased Histamine Release [PE] Cell-mediated Immunity [PE] Increased IgG Production [PE] Decreased Embryonic Implantation [PE] Decreased Sperm Motility [PE] Inhibit Ovum Fertilization [PE] |
| Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`. | |
| Pharmacologic Class CS: | Allergens [CS] Bee Venoms [CS] Copper [CS] Catecholamines [CS] |
| Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient]. | |
| Pharmacologic Class: | Adrenergic alpha-Agonists [MoA] Adrenergic beta-Agonists [MoA] Allergens [CS] Anticholinergic [EPC] Bee Venoms [CS] Catecholamine [EPC] Catecholamines [CS] Cell-mediated Immunity [PE] Cholinergic Antagonists [MoA] Cholinergic Muscarinic Antagonist [EPC] Cholinergic Muscarinic Antagonists [MoA] Copper [CS] Copper-containing Intrauterine Device [EPC] Decreased Embryonic Implantation [PE] Decreased Sperm Motility [PE] Increased Histamine Release [PE] Increased IgG Production [PE] Inhibit Ovum Fertilization [PE] Standardized Insect Venom Allergenic Extract [EPC] alpha-Adrenergic Agonist [EPC] beta-Adrenergic Agonist [EPC] |
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. | |
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|---|---|---|---|
| 43742-1506-1 | 30 mL in 1 BOTTLE, DROPPER (43742-1506-1) | 25 Jul, 2019 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. | ||||
* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.